Dr. Emily Chan, from Vanderbilt-Ingram Cancer Center, Discusses the VEGF-Trap Agent Aflibercept
Emily Chan, MD, PhD
Advertisement
Articles by Emily Chan, MD, PhD
Dr. Emily Chan from Vanderbilt-Ingram Cancer Center Discusses the Adjuvant Colorectal NO147 Trial
Advertisement
Latest Updated Articles
Dr. Chan on the Adjuvant Colorectal NO147 TrialPublished: November 30th 2011 | Updated:
Dr. Chan Discusses the VEGF-Trap Agent AfliberceptPublished: January 13th 2012 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5